ASX - By Stock
|
PER |
Re:
For General Information
|
|
Ressy
|
3.5K |
1.0M |
7 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
Ressy
|
124 |
36K |
12 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
124
|
36K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Ressy
|
228 |
85K |
25 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
228
|
85K
|
25
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Ressy
|
168 |
63K |
22 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
168
|
63K
|
22
|
|
Charts
|
PER |
Re:
Chart
|
|
Ressy
|
5.9K |
2.2M |
10 |
21/07/22 |
21/07/22 |
Charts
|
5.9K
|
2.2M
|
10
|
|
Charts
|
PER |
Re:
Chart
|
|
Ressy
|
5.9K |
2.2M |
3 |
19/07/22 |
19/07/22 |
Charts
|
5.9K
|
2.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
Ressy
|
93 |
23K |
16 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
93
|
23K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
Ressy
|
86 |
23K |
9 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Investor Presentation
|
|
Ressy
|
85 |
26K |
0 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
85
|
26K
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Ressy
|
3.5K |
1.0M |
7 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
Charts
|
PER |
Re:
Chart
|
|
Ressy
|
5.9K |
2.2M |
4 |
20/05/22 |
20/05/22 |
Charts
|
5.9K
|
2.2M
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
Ressy
|
5.9K |
2.2M |
3 |
15/05/22 |
15/05/22 |
Charts
|
5.9K
|
2.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Ressy
|
3.5K |
1.0M |
1 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE
|
|
Ressy
|
77 |
31K |
1 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
77
|
31K
|
1
|
|
ASX - By Stock
|
PER |
Re:
UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE
|
|
Ressy
|
77 |
31K |
3 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
77
|
31K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Entitlement Offer Closing Date Extended
|
|
Ressy
|
61 |
17K |
5 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
61
|
17K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Ressy
|
166 |
49K |
4 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
166
|
49K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Ressy
|
166 |
49K |
27 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
166
|
49K
|
27
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Ressy
|
166 |
49K |
31 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
49K
|
31
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Ressy
|
143 |
49K |
14 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
49K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
Ressy
|
1.0K |
358K |
21 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
1.0K
|
358K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
Ressy
|
1.0K |
358K |
19 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
1.0K
|
358K
|
19
|
|
ASX - By Stock
|
PER |
Re:
Who funds trial - poll
|
|
Ressy
|
34 |
12K |
20 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
34
|
12K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Ressy
|
34 |
10K |
5 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
34
|
10K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
Ressy
|
1.0K |
358K |
0 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
1.0K
|
358K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Anp at world muscle society
|
|
Ressy
|
42 |
11K |
10 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
42
|
11K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Pfizer takeover of CD47 blocking Co.
|
|
Ressy
|
41 |
13K |
4 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
41
|
13K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
Ressy
|
174 |
46K |
17 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
174
|
46K
|
17
|
|
Charts
|
PER |
Re:
Chart
|
|
Ressy
|
5.9K |
2.2M |
12 |
23/06/21 |
23/06/21 |
Charts
|
5.9K
|
2.2M
|
12
|
|
ASX - By Stock
|
FFR Algorithmic Trading |
Re:
What are Director’s paying themselves!
|
|
Ressy
|
1 |
1.1K |
12 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
1
|
1.1K
|
12
|
|